Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/195526
Title: Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
Author: Benejam, Bessy
Videla, Laura
Vilaplana, Eduard
Barroeta, Isabel
Carmona Iragui, María
Altuna, Miren
Valldeneu, Silvia
Fernández, Susana
Giménez, Sandra
Iulita, Maria Florencia
Garzón, Diana
Bejanin, Alexandre
Bartrés Faz, David
Videla Cés, Sebastià
Alcolea, Daniel
Blesa González, Rafael
Lleó Bisa, Alberto
Fortea, Juan
Keywords: Síndrome de Down
Malaltia d'Alzheimer
Demència
Teràpia cognitiva
Tests neuropsicològics
Anàlisi de conducta
Down syndrome
Alzheimer's disease
Dementia
Cognitive therapy
Neuropsychological tests
Behavioral assessment
Issue Date: 25-May-2020
Publisher: John Wiley & Sons
Abstract: Introduction: We aimed to define prodromal Alzheimer's disease (AD) and AD dementia using normative neuropsychological data in a large population-based cohort of adults with Down syndrome (DS). Methods: Cross-sectional study. DS participants were classified into asymptomatic, prodromal AD and AD dementia, based on neurologist's judgment blinded to neuropsychological data (Cambridge Cognitive Examination for Older Adults with Down's syndrome [CAMCOG-DS] and modified Cued Recall Test [mCRT]). We compared the cutoffs derived from the normative data in young adults with DS to those from receiveroperating characteristic curve (ROC) analysis. Results: Diagnostic performance of the CAMCOG-DS and modified Cued Recall Test (mCRT) in subjects with mild and moderate levels of intellectual disability (ID) was high, both for diagnosing prodromal AD and AD dementia (area under the curve [AUC] 0.73- 0.83 and 0.90-1, respectively). The cutoffs derived from the normative data were similar to those derived from the ROC analyses. Discussion: Diagnosing prodromal AD and AD dementia in DS with mild and moderate ID using population norms for neuropsychological tests is possible with high diagnostic accuracy.
Note: Reproducció del document publicat a: https://doi.org/10.1002/dad2.12047
It is part of: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020, vol. 12, num. 1, p. e12047
URI: https://hdl.handle.net/2445/195526
Related resource: https://doi.org/10.1002/dad2.12047
ISSN: 1552-5260
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut de Neurociències (UBNeuro))

Files in This Item:
File Description SizeFormat 
708553.pdf1.7 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons